Why the study?
What are the long-term outcomes and complication rates of bioprosthetic valve replacement in selected patients?
What are the long-term outcomes and complication rates of bioprosthetic valve replacement in selected patients?
Bioprosthetic valves demonstrate acceptable long-term performance with 83% freedom from valve failure at 8 years, supporting their use in selected patients.
Answers are grounded in this paper and cite their sources.
May support durability in selected cases; leaves open generalizability pending larger prospective studies.
From January 1975 to September 1983, 615 patients underwent valve replacement using 698 bioprosthetic valves for selected indications. This group represents the third of all patients having valve replacement during the same period. Children younger than 15 years were excluded. The mean pre-operative functional class was 2.9. The early mortality rate was less than 5% and the follow-up range 3 months to 9 years (3.2 yrs). The symptomatic improvement was attested by a mean post-operative functional class of 1.4. In a linear study the following rates of valve related complications were noted: thromboembolism 4.6%, endocarditis 2.5%, primary tissue valve degeneration 1.1%, paraprosthetic leak 2.5%. In an actuarial study, at 8 years, 83% of patients were free from any valve failure. The probability rates of complications were the following: thromboembolic events 8%, endocarditis 5%, degeneration 3%, reoperation 7%. The probability of survival at 8 yrs was 69% and the probability rates of late mortality were noted as follow: cardiac related mortality 27%, valve-related mortality 4%. Despite an expected increasing rate of degeneration, the results warrant the use of bioprostheses in a selected group of patients.
No takes yet. Share an insight, caveat, or question.
Bloch et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: